Moreover, immunosuppressive TREM2+ macrophages were recruited by tumour cells through the CCL15‐CCR1 axis to enhance immunosuppressive microenvironment and promote NAFLD‐related HCC progression. The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatotic liver disease.